Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial

OBJECTIVES: To study the efficacy and safety of fasinumab in moderate-to-severe, chronic low back pain (CLBP). METHODS: In this phase II/III, double-blind, placebo-controlled study, patients with CLBP aged ≥35 years with inadequate pain relief/intolerance to acetaminophen, non-steroidal anti-inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Dakin, Paula, Kivitz, Alan J, Gimbel, Joseph S, Skrepnik, Nebojsa, DiMartino, Stephen J, Emeremni, Chetachi A, Gao, Haitao, Stahl, Neil, Weinreich, David M, Yancopoulos, George D, Geba, Gregory P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Pain
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958114/
https://www.ncbi.nlm.nih.gov/pubmed/33199274
http://dx.doi.org/10.1136/annrheumdis-2020-217259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958114/
https://www.ncbi.nlm.nih.gov/pubmed/33199274
http://dx.doi.org/10.1136/annrheumdis-2020-217259

Ejemplares similares